BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 30262735)

  • 1. Cannabinoid Delivery Systems for Pain and Inflammation Treatment.
    Bruni N; Della Pepa C; Oliaro-Bosso S; Pessione E; Gastaldi D; Dosio F
    Molecules; 2018 Sep; 23(10):. PubMed ID: 30262735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain.
    Stella B; Baratta F; Della Pepa C; Arpicco S; Gastaldi D; Dosio F
    Drugs; 2021 Sep; 81(13):1513-1557. PubMed ID: 34480749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
    McCarberg BH; Barkin RL
    Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoids:their role in pain and palliation.
    McCarberg BH
    J Pain Palliat Care Pharmacother; 2007; 21(3):19-28. PubMed ID: 18032352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Biodegradable Polymers Can be Effective Drug Delivery Systems for Cannabinoids? Prospectives and Challenges.
    Sobieraj J; Strzelecka K; Sobczak M; Oledzka E
    Int J Nanomedicine; 2024; 19():4607-4649. PubMed ID: 38799700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of cannabinoids.
    Grotenhermen F
    Clin Pharmacokinet; 2003; 42(4):327-60. PubMed ID: 12648025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permeation-Enhancing Strategies for Transdermal Delivery of Cannabinoids.
    Torabi A; Madsen FB; Skov AL
    Cannabis Cannabinoid Res; 2024 Apr; 9(2):449-463. PubMed ID: 37751171
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic potential of cannabinoids in CNS disease.
    Croxford JL
    CNS Drugs; 2003; 17(3):179-202. PubMed ID: 12617697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers.
    Paudel KS; Hammell DC; Agu RU; Valiveti S; Stinchcomb AL
    Drug Dev Ind Pharm; 2010 Sep; 36(9):1088-97. PubMed ID: 20545522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoids: the separation of central from peripheral effects on a structural basis.
    Evans FJ
    Planta Med; 1991 Oct; 57(7):S60-7. PubMed ID: 1659702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD.
    Drugs R D; 2003; 4(5):306-9. PubMed ID: 12952500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoids in the treatment of pain and spasticity in multiple sclerosis.
    Smith PF
    Curr Opin Investig Drugs; 2002 Jun; 3(6):859-64. PubMed ID: 12137404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data.
    Tanda G; Goldberg SR
    Psychopharmacology (Berl); 2003 Sep; 169(2):115-34. PubMed ID: 12827346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain.
    Burns TL; Ineck JR
    Ann Pharmacother; 2006 Feb; 40(2):251-60. PubMed ID: 16449552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pain relief with cannabinoids-- the importance of endocannabinoids and cannabinoids for pain therapy].
    Karst M; Bernateck M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2008 Jul; 43(7-8):522-8. PubMed ID: 18671173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal Delivery of Cannabidiol for the Management of Acute Inflammatory Pain: A Comprehensive Review of the Literature.
    Lefebvre È; Tawil N; Yahia L
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoids in clinical practice.
    Williamson EM; Evans FJ
    Drugs; 2000 Dec; 60(6):1303-14. PubMed ID: 11152013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in the therapeutic potential of cannabinoids.
    Corey S
    P R Health Sci J; 2005 Mar; 24(1):19-26. PubMed ID: 15895873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
    Pertwee RG
    Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.